Advisors Asset Management, Inc. Exelixis, Inc. Transaction History
Advisors Asset Management, Inc.
- $5.23 Billion
- Q4 2024
A detailed history of Advisors Asset Management, Inc. transactions in Exelixis, Inc. stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 23,951 shares of EXEL stock, worth $926,664. This represents 0.02% of its overall portfolio holdings.
Number of Shares
23,951
Previous 19,853
20.64%
Holding current value
$926,664
Previous $515,000
54.76%
% of portfolio
0.02%
Previous 0.01%
Shares
28 transactions
Others Institutions Holding EXEL
# of Institutions
566Shares Held
251MCall Options Held
1.45MPut Options Held
1.13M-
Black Rock Inc. New York, NY33.5MShares$1.3 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.4MShares$1.14 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA23.4MShares$907 Million4.16% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.3MShares$592 Million0.8% of portfolio
-
State Street Corp Boston, MA11.4MShares$442 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $12.5B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...